Lombard Medical Technologies (LSE:LMT) EBIT per Share : £-0.41 (TTM As of Dec. 2012)

View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies EBIT per Share?

Lombard Medical Technologies's EBIT per Share for the six months ended in Dec. 2012 was £-0.41. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.41.

During the past 3 years, the average EBIT per Share Growth Rate was -23.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was -48.80% per year. During the past 10 years, the average EBIT per Share Growth Rate was -50.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Lombard Medical Technologies's EBIT per Share or its related term are showing as below:

LSE:LMT' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -72.3 Med: -51.2 Max: 6.9
Current: -23.1

During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Lombard Medical Technologies was 6.90% per year. The lowest was -72.30% per year. And the median was -51.20% per year.

LSE:LMT's 3-Year EBIT Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 5.7 vs LSE:LMT: -23.10

Lombard Medical Technologies's EBIT for the six months ended in Dec. 2012 was £-8.24 Mil.

Lombard Medical Technologies EBIT per Share Historical Data

The historical data trend for Lombard Medical Technologies's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies EBIT per Share Chart

Lombard Medical Technologies Annual Data

Trend

Sep02

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

EBIT per Share

Get a 7-Day Free Trial

-16.95

-2.08

-0.84

-0.70

-0.41

Lombard Medical Technologies Semi-Annual Data
	Sep02	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
EBIT per Share	Get a 7-Day Free Trial					-16.62	-1.91	-0.79	-0.56	-0.41

Lombard Medical Technologies EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Lombard Medical Technologies's EBIT per Share for the fiscal year that ended in Dec. 2012 is calculated as

	EBIT per Share		(A: Dec. 2012 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-8.244	/	20.162
=	-0.41

Lombard Medical Technologies's EBIT per Share for the quarter that ended in Dec. 2012 is calculated as

	EBIT per Share		(Q: Dec. 2012 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-8.244	/	20.162
=	-0.41

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.41

Lombard Medical Technologies (LSE:LMT) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Lombard Medical Technologies EBIT per Share Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lombardmedical.com

Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.